Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia.
Chen-Wen FangCheng-Yang HsiehHsin-Yi YangChing-Fang TsaiSheng-Feng SungPublished in: European stroke journal (2024)
Compared to warfarin, DOACs, whether as a group or apixaban, dabigatran, or rivaroxaban individually, were associated with a reduced risk of the composite outcome in elderly patients with concurrent AF and dementia.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- mild cognitive impairment
- oral anticoagulants
- catheter ablation
- left atrial
- cognitive impairment
- left atrial appendage
- venous thromboembolism
- heart failure
- percutaneous coronary intervention
- middle aged
- community dwelling
- squamous cell carcinoma
- acute coronary syndrome
- coronary artery disease
- pulmonary embolism
- mitral valve